CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Perdagangan Black Diamond Therapeutics, Inc. - BDTX CFD

1.8672
4.47%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0356
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.024874%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
0.002651%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.7873
Open* 1.7673
1-Year Change* -35.73%
Day's Range* 1.7673 - 1.8672
52 wk Range 1.18-4.08
Average Volume (10 days) 74.76K
Average Volume (3 months) 2.69M
Market Cap 68.95M
P/E Ratio -100.00K
Shares Outstanding 36.48M
Revenue N/A
EPS -2.51
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date May 9, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 31, 2023 1.8672 0.0599 3.31% 1.8073 1.8672 1.7573
Mar 30, 2023 1.7873 -0.0200 -1.11% 1.8073 1.8472 1.7074
Mar 29, 2023 1.8472 0.0199 1.09% 1.8273 1.8872 1.7573
Mar 28, 2023 1.8473 0.0500 2.78% 1.7973 1.8473 1.7274
Mar 27, 2023 1.8073 0.0299 1.68% 1.7774 1.8073 1.7074
Mar 24, 2023 1.8073 0.0300 1.69% 1.7773 1.8572 1.7773
Mar 23, 2023 1.8372 0.0299 1.65% 1.8073 1.9072 1.7773
Mar 22, 2023 1.7973 -0.0499 -2.70% 1.8472 1.9072 1.7673
Mar 21, 2023 1.8972 0.2197 13.10% 1.6775 1.8972 1.6775
Mar 20, 2023 1.6875 0.0899 5.63% 1.5976 1.6875 1.5676
Mar 17, 2023 1.5976 -0.0699 -4.19% 1.6675 1.6875 1.5776
Mar 16, 2023 1.6375 -0.0100 -0.61% 1.6475 1.7074 1.6175
Mar 15, 2023 1.6775 -0.0100 -0.59% 1.6875 1.7374 1.5976
Mar 14, 2023 1.7474 0.1698 10.76% 1.5776 1.7774 1.5376
Mar 13, 2023 1.5177 0.2197 16.93% 1.2980 1.9072 1.2980
Mar 10, 2023 1.3180 -0.1298 -8.97% 1.4478 1.4478 1.2181
Mar 9, 2023 1.4478 -0.1897 -11.58% 1.6375 2.1968 1.4378
Mar 8, 2023 1.6775 0.0799 5.00% 1.5976 1.7274 1.5676
Mar 7, 2023 1.6675 -0.1298 -7.22% 1.7973 1.7973 1.6675
Mar 6, 2023 1.7873 -0.0399 -2.18% 1.8272 1.8872 1.7773

Black Diamond Therapeutics, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Total Operating Expense 92.828 126.872 69.57 29.332 8.904
Selling/General/Admin. Expenses, Total 28.391 30.043 21.361 7.579 1.954
Research & Development 64.437 96.829 48.209 21.753 6.95
Unusual Expense (Income) 0
Operating Income -92.828 -126.872 -69.57 -29.332 -8.904
Interest Income (Expense), Net Non-Operating -0.219 3.464 4.041 -5.932 -0.011
Other, Net -0.354 -2.188 -1.725 0.006 -0.016
Net Income Before Taxes -91.169 -125.596 -67.254 -35.258 -8.931
Net Income After Taxes -91.169 -125.596 -67.254 -35.258 -8.931
Net Income Before Extra. Items -91.169 -125.596 -67.254 -35.258 -8.931
Net Income -91.169 -125.596 -67.254 -35.258 -8.931
Income Available to Common Excl. Extra. Items -91.169 -125.596 -67.254 -35.258 -8.931
Income Available to Common Incl. Extra. Items -91.169 -125.596 -67.254 -35.258 -8.931
Diluted Net Income -91.169 -125.596 -67.254 -35.258 -8.931
Diluted Weighted Average Shares 36.3256 36.189 32.9071 32.6364 32.6364
Diluted EPS Excluding Extraordinary Items -2.50977 -3.47056 -2.04375 -1.08033 -0.27365
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -2.57122 -3.47056 -2.04375 -1.08033 -0.27365
Gain (Loss) on Sale of Assets 2.232
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 0 0 0 0 0
Total Operating Expense 21.852 22.124 23.173 25.679 26.08
Selling/General/Admin. Expenses, Total 7.243 6.277 6.978 7.893 6.416
Research & Development 14.609 15.847 16.195 17.786 19.664
Operating Income -21.852 -22.124 -23.173 -25.679 -26.08
Interest Income (Expense), Net Non-Operating -1.573 0.562 0.386 0.406 0.588
Other, Net 0.115 -0.092 -0.143 -0.234 -0.375
Net Income Before Taxes -21.078 -21.654 -22.93 -25.507 -25.867
Net Income After Taxes -21.078 -21.654 -22.93 -25.507 -25.867
Net Income Before Extra. Items -21.078 -21.654 -22.93 -25.507 -25.867
Net Income -21.078 -21.654 -22.93 -25.507 -25.867
Income Available to Common Excl. Extra. Items -21.078 -21.654 -22.93 -25.507 -25.867
Income Available to Common Incl. Extra. Items -21.078 -21.654 -22.93 -25.507 -25.867
Diluted Net Income -21.078 -21.654 -22.93 -25.507 -25.867
Diluted Weighted Average Shares 36.3902 36.3462 36.2939 36.2713 36.2303
Diluted EPS Excluding Extraordinary Items -0.57922 -0.59577 -0.63179 -0.70323 -0.71396
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.64056 -0.59577 -0.63179 -0.70323 -0.71396
Gain (Loss) on Sale of Assets 2.232
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 215.703 319.554 155.714 51.684 7.914
Cash and Short Term Investments 209.786 315.067 154.666 51.66 7.878
Cash & Equivalents 65.799 34.605 154.666 51.66 7.878
Prepaid Expenses 5.917 4.487 1.048 0.024 0.036
Total Assets 247.682 329.67 158.295 51.826 8.021
Property/Plant/Equipment, Total - Net 30.74 8.787 0.164 0.134 0.102
Property/Plant/Equipment, Total - Gross 31.109 8.951 0.276 0.234 0.158
Accumulated Depreciation, Total -0.369 -0.164 -0.112 -0.1 -0.056
Other Long Term Assets, Total 1.239 1.329 2.417 0.008 0.005
Total Current Liabilities 23.642 14.218 4.863 2.575 2.23
Accounts Payable 4.107 2.538 1.964 0.416 0.152
Accrued Expenses 19.535 11.68 2.899 0.452 0.158
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 1.707 1.92
Total Liabilities 51.782 21.912 4.879 6.598 2.238
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 28.14 7.694 0.016 4.023 0.008
Total Equity 195.9 307.758 153.416 45.228 5.783
Preferred Stock - Non Redeemable, Net 0 0 60.77 12.458
Common Stock 0.005 0.005 0.001 0.001 0.001
Additional Paid-In Capital 440.129 425.363 3.812 0.169 0.105
Retained Earnings (Accumulated Deficit) -243.82 -118.224 -50.97 -15.712 -6.781
Total Liabilities & Shareholders’ Equity 247.682 329.67 158.295 51.826 8.021
Total Common Shares Outstanding 36.2346 36.0784 32.6364 32.6364 32.6364
Redeemable Preferred Stock 0 0 200.573
Short Term Investments 143.987 280.462
Other Equity, Total -0.414 0.614
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 188.304 215.703 241.546 270.947 297.347
Cash and Short Term Investments 179.739 209.786 235.008 263.47 290.055
Cash & Equivalents 54.081 65.799 46.603 37.324 14.105
Short Term Investments 125.658 143.987 188.405 226.146 275.95
Prepaid Expenses 8.565 5.917 6.538 7.477 7.292
Total Assets 219.482 247.682 274.126 287.882 313.259
Property/Plant/Equipment, Total - Net 29.945 30.74 31.258 15.614 14.589
Property/Plant/Equipment, Total - Gross 30.439 31.109 31.504 15.817 14.772
Accumulated Depreciation, Total -0.494 -0.369 -0.246 -0.203 -0.183
Other Long Term Assets, Total 1.233 1.239 1.322 1.321 1.323
Total Current Liabilities 19.469 23.642 26.361 23.486 18.704
Accounts Payable 1.883 4.107 4.859 5.03 4.616
Accrued Expenses 17.586 19.535 21.502 18.456 14.088
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 46.922 51.782 55.178 36.862 32.506
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 27.453 28.14 28.817 13.376 13.802
Total Equity 172.56 195.9 218.948 251.02 280.753
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.005 0.005 0.005 0.005 0.005
Additional Paid-In Capital 443.657 440.129 436.753 433.68 428.938
Retained Earnings (Accumulated Deficit) -269.327 -243.82 -217.953 -182.876 -148.525
Other Equity, Total -1.775 -0.414 0.143 0.211 0.335
Total Liabilities & Shareholders’ Equity 219.482 247.682 274.126 287.882 313.259
Total Common Shares Outstanding 36.2876 36.2346 36.2289 36.2058 36.1472
Redeemable Preferred Stock 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -91.169 -125.596 -67.254 -35.258 -8.931
Cash From Operating Activities -85.082 -100.148 -52.146 -24.674 -8.454
Cash From Operating Activities 0.508 0.205 0.052 0.047 0.044
Non-Cash Items 15.48 18.223 10.014 10.074 0.079
Changes in Working Capital -9.901 7.02 5.042 0.463 0.354
Cash From Investing Activities 53.366 130.613 -281.691 -0.021 -0.076
Capital Expenditures -0.192 -2.71 -0.142 -0.021 -0.076
Other Investing Cash Flow Items, Total 53.558 133.323 -281.549 0
Cash From Financing Activities 0.177 0.729 214.944 127.756 52.312
Financing Cash Flow Items 0 -1.743 0
Issuance (Retirement) of Stock, Net 0.177 0.729 214.944 129.499 52.312
Issuance (Retirement) of Debt, Net 0
Net Change in Cash -31.539 31.194 -118.893 103.061 43.782
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Net income/Starting Line -91.169 -70.091 -48.437 -25.507 -125.596
Cash From Operating Activities -85.082 -63.143 -46.667 -28.6 -100.148
Cash From Operating Activities 0.508 0.382 0.253 0.125 0.205
Non-Cash Items 15.48 11.804 8.366 4.293 18.223
Changes in Working Capital -9.901 -5.238 -6.849 -7.511 7.02
Cash From Investing Activities 53.366 51.044 36.537 16.729 130.613
Capital Expenditures -0.192 -0.192 -0.2 -0.007 -2.71
Other Investing Cash Flow Items, Total 53.558 51.236 36.737 16.736 133.323
Cash From Financing Activities 0.177 0.205 0.153 0.153 0.729
Issuance (Retirement) of Stock, Net 0.177 0.205 0.153 0.153 0.729
Net Change in Cash -31.539 -11.894 -9.977 -11.718 31.194
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Bellevue Asset Management AG Investment Advisor 14.8045 5400839 87850 2022-12-31 LOW
New Enterprise Associates (NEA) Venture Capital 9.4535 3448757 -1088 2022-12-31 LOW
RA Capital Management, LP Hedge Fund 7.0993 2589904 0 2022-12-31 LOW
Boxer Capital, L.L.C. Hedge Fund 5.523 2014858 0 2022-12-31 LOW
Invus Public Equities Advisors, LLC Investment Advisor 4.5133 1646517 0 2022-12-31 LOW
Epstein (David M) Individual Investor 2.5725 938479 -23090 2022-03-15 LOW
Citadel Advisors LLC Hedge Fund 2.1211 773798 733149 2022-12-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.0766 757585 487 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.7856 651395 -182376 2022-12-31 LOW
Millennium Management LLC Hedge Fund 1.4379 524557 177577 2022-12-31 HIGH
Two Sigma Investments, LP Hedge Fund 0.9763 356164 -66329 2022-12-31 HIGH
Newtyn Management, LLC Hedge Fund 0.8635 315000 -35000 2022-12-31 MED
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.7831 285681 -70820 2022-12-31 LOW
EcoR1 Capital, LLC Hedge Fund 0.7734 282131 282131 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7272 265290 743 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.6047 220613 2913 2022-12-31 HIGH
K2 & Associates Investment Management Inc. Hedge Fund 0.4336 158192 -873319 2022-12-31 HIGH
Federated Hermes MDTA LLC Investment Advisor/Hedge Fund 0.4255 155219 -4329 2022-12-31 HIGH
BioImpact Capital LLC Investment Advisor/Hedge Fund 0.3972 144888 -95000 2022-12-31 LOW
Tekla Capital Management LLC Investment Advisor 0.3618 131990 0 2022-12-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Bio Therapeutic Drugs

One Main Street, 14Th Floor
CAMBRIDGE
MASSACHUSETTS 02142
US

Income Statement

  • Annual
  • Quarterly

People also watch

BTC/USD

28,392.85 Price
-0.260% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

Natural Gas

2.20 Price
+3.540% 1D Chg, %
Biaya inap posisi Long -0.4092%
Biaya inap posisi short 0.3873%
Waktu biaya inap 21:00 (UTC)
Spread 0.005

Oil - Crude

75.76 Price
+1.830% 1D Chg, %
Biaya inap posisi Long -0.0156%
Biaya inap posisi short -0.0063%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Gold

1,969.66 Price
-0.550% 1D Chg, %
Biaya inap posisi Long -0.0185%
Biaya inap posisi short 0.0102%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda